PAPER Aquino D, Contarino V, Albanese A, Minati L, Farina L, Grisoli M, Elia A, Bruzzone MG, Chiapparini L
SEARCH RESULTS
329940 RESULTS
PAPER Chen CM, Wu CH, Hsieh CH, Lin CH, Chen IC, Chen YC, Lee LC, Lee CM, Tseng YC, Lee-Chen GJ, Wu YR
HTRA2 variations in Taiwanese Parkinson's disease.
J Neural Transm. 2013 Dec 12; PubMed: 24337630PAPER Spiegel J, Uhrig I, Krick C, Behnke S, Fassbender K, Dillmann U
Performance of repetitive alternating elbow movements in Parkinson's disease.
Eur Neurol. 2014;71(1-2):84-8. Epub 2013 Dec 5 PubMed: 24335107PAPER Liu RR, Zhou LL, Cheng X, Sun MX, Hu YB, Chen SF, Zhang X, Zhu JH
CCDC62 variant rs12817488 is associated with the risk of Parkinson's disease in a Han Chinese population.
Eur Neurol. 2014;71(1-2):77-83. Epub 2013 Dec 4 PubMed: 24335092PAPER Du G, Lewis MM, Sterling NW, Kong L, Chen H, Mailman RB, Huang X
Microstructural changes in the substantia nigra of asymptomatic agricultural workers.
Neurotoxicol Teratol. 2014 Jan-Feb;41:60-4. Epub 2013 Dec 12 PubMed: 24334261PAPER Parish CL, Thompson LH
Modulating Wnt signaling to improve cell replacement therapy for Parkinson's disease.
J Mol Cell Biol. 2014 Feb;6(1):54-63. Epub 2013 Dec 13 PubMed: 24334258PAPER Freestone PS, Guatteo E, Piscitelli F, di Marzo V, Lipski J, Mercuri NB
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta.
Neuropharmacology. 2014 Apr;79:467-75. Epub 2013 Dec 12 PubMed: 24334069PAPER Hernandez ME, Rembao JD, Hernandez-Baltazar D, Castillo-Rodriguez RA, Tellez-Lopez VM, Flores-Martinez YM, Orozco-Barrios CE, Rubio HA, Sánchez-García A, Ayala-Davila J, Arango-Rodriguez ML, Pavón L, Mejia-Castillo T, Forgez P, Martinez-Fong D
Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALB/c mice.
Nanomedicine. 2014 May;10(4):745-54. Epub 2013 Dec 10 PubMed: 24333586PAPER Ramírez-Moreno JM, Salguero Bodes I, Romaskevych O, Duran-Herrera MC
Broad bean (Vicia faba) consumption and Parkinson's disease: A natural source of L-dopa to consider.
Neurologia. 2013 Dec 10; PubMed: 24332774PAPER Patel N, Jankovic J, Hallett M
Sensory aspects of movement disorders.
Lancet Neurol. 2014 Jan;13(1):100-12. PubMed: 24331796PAPER Lee YH, Song GG
BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
J Mot Behav. 2014;46(1):59-66. Epub 2013 Dec 12 PubMed: 24329127PAPER Ramirez-Zamora A, Molho E
Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions.
Expert Rev Neurother. 2014 Jan;14(1):93-103. Epub 2013 Dec 13 PubMed: 24328720PAPER Shoup TM, Yokell DL, Rice PA, Jackson RN, Livni E, Johnson KA, Brady TJ, Vasdev N
A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807.
J Labelled Comp Radiopharm. 2013 Dec;56(14):736-40. Epub 2013 Jul 24 PubMed: 24339014PAPER Tatsumi S, Mimuro M, Iwasaki Y, Takahashi R, Kakita A, Takahashi H, Yoshida M
Argyrophilic grains are reliable disease-specific features of corticobasal degeneration.
J Neuropathol Exp Neurol. 2014 Jan;73(1):30-8. PubMed: 24335531PAPER Chen S, St Jean P, Borland J, Song I, Yeo AJ, Piscitelli S, Rubio JP
Evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics.
Pharmacogenomics. 2014 Jan;15(1):9-16. PubMed: 24329186Current Filters
No filters selected